期刊文献+

利用PCR技术构建GM-CSF/Fc_(γ2)^-融合蛋白真核表达载体

CONSTRUCTION AND EXPRESSION OF THE VECTOR OF hGM-CSF/Fc_(γ2)^- FUSION PROTEIN
下载PDF
导出
摘要 目的 对融合基因GM -CSF Fcγ2 进行定点突变 ,去除其补体结合位点 ,构建GM -CSF Fcγ2-融合蛋白真核表达载体。方法 通过设计突变引物 ,利用PCR定点突变技术扩增融合基因GM -CSF Fcγ2-。并通过T -A克隆策略 ,把突变后的融合基因GM -CSF Fcγ2-重组到真核表达载体pRc CMV2中 ,构建真核表达质粒pRc CMV2 GM -CSF Fcγ2-并经过酶切和测序确证。结果 成功对融合基因GM -CSF Fcγ2-进行了突变 ,构建了真核表达载体pRc CMV2 GM -CSF Fcγ2-。 Objective To eliminate the C1q binding site of the Fc fragment of GM-CSF/Fc γ2 - fusion protein and construct the eukaryotic expression vector of GM-CSF/Fc γ2 - fusion protein. Methods Replace the c1q binding motif Glu318, Lys320, Lys322 of fusion protein GM-CSF/Fc γ2 - with Ala residues by PCR oligonucieotide site-directed mutagenesis . Then, the mutated GM-CSF/ Fc γ2 - was cloned into eukaryotic expression plasmid pRc/CMV2 by the strategy of T-A cloning, and the result was confirmed by restriction enzyme cutting and sequence analysis. Results fusion protein GM-CSF/Fc γ2 - was mutated successfully, and the vector of the eukaryotic expression pRc/CMV2/GM-CSF/Fc γ2 - was constructed. Conclusion The methde of PCR olionucleotide site-directed mutagenesis is feasible.
出处 《济宁医学院学报》 2001年第1期30-32,共3页 Journal of Jining Medical University
关键词 融合蛋白 定点突变 基因克隆 聚合酶链反应 Fusion protein PCR site-directed mutagenesis gene clone
  • 相关文献

参考文献15

  • 1龙振洲.医学免疫学[M].北京:人民卫生出版社,1994.133.
  • 2Alexander R, et al. The binding site for C1q on IgG. Nature, 1988,332:738
  • 3Chamow SM, Ashkenazi A. Immunoadhesins: principles and applications.TrendsBiotechnol, 1996,14:52
  • 4Weinblatt - ME, et al. A trial of etancercept , a recombinant tumor necrosis factorreceptor: Fc fusion protein, in patient with rheumatoid arthritis receiving methotrexal .N - Engl - J - Med. 1999, Jan 28 ;340(4) :253
  • 5Pancook, J. D., Becker, J. C., Gillies, S. D., et al. Eradication of establishedhepatic human neuroblastoma metastases in mice with severe combined immunodeficiency byantibody - targeted interleukin - 2. Cancer Immunol. Immuother. 1996,42:88
  • 6Becker, J. C., Pancook, J. D., Gillies, S. D., et al. Eradication of human hepaticand pulmonary melanoma metastases in SCID mice by antibodyinterleukin2 fusion protein.Proc. Natl. Acad. Sci. USA, 1996,93: 2702
  • 7Pancook, J. D., Becker, J. C., Gillies, S. D., e tal. T cell - mediated eradicationof murine metastases melanoma induced by targeted interleukin 2 therapy. J.Exp. Med.1996,183:2361
  • 8Xiang ,R. ,Lode,H.N. ,Dolman,C.S., et al. Elimination of established coloncarcinoma metastases by antibody - targeted interleukin - 2 fusion protein therapy. CancerRes. 1997,57:4948
  • 9Lode,H.N., Xiang ,R. ,Dreier,T., et al. Natural killer cell - mediated eradicationneuroblastoma metastases to bone marrow by by targeted interleukin 2 therapy. Blood,1998,91:1706
  • 10Vadham R.s. PIXY321 ( GM - CSF/IL - 3 fusion protein): biology and early clinicaldevelopment . Stem Cells 1994 12:253

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部